SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-195522
Filing Date
2020-07-20
Accepted
2020-07-20 16:40:52
Documents
8
Period of Report
2020-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d51427d8k.htm 8-K 36652
2 EX-5.1 d51427dex51.htm EX-5.1 9169
3 EX-10.1 d51427dex101.htm EX-10.1 201920
4 EX-10.2 d51427dex102.htm EX-10.2 89267
5 EX-23.1 d51427dex231.htm EX-23.1 1816
6 EX-99.1 d51427dex991.htm EX-99.1 9075
7 GRAPHIC g51427g10o14.jpg GRAPHIC 6672
8 GRAPHIC g51427g45o06.jpg GRAPHIC 4580
  Complete submission text file 0001193125-20-195522.txt   365132
Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 201036757
SIC: 2834 Pharmaceutical Preparations